
Opinion|Videos|July 10, 2024
Improvement in Management of Duchenne Muscular Dystrophy in Recent Years
Author(s)Emma Ciafaloni, MD
A neurologist discusses how recent approvals of therapies for Duchenne muscular dystrophy have improved patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- How have these recent approvals improved the management of Duchenne muscular dystrophy (DMD)?
- Share your experience with recent approvals in DMD.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Grants Fast Track Designation to T-Cell Agent CK0803 for ALS
2
5-Year Data Support Safety of MRI-Guided AAV2-GDNF Gene Therapy in Advanced Parkinson Disease
3
AHA/ASA Issue New Guideline for Adult Stroke Rehabilitation and Recovery
4
Top 5 Spinal Muscular Atrophy Headlines of 2026: What Neurologists Should Know
5



















